Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.

CONCLUSIONS: This study showed that visceral obesity, insulin-resistance, lipid and glucose metabolism alterations are associated with prostate volume and growth during T replacement therapy in KS, independently from androgen or estrogen levels. This latter findings might provide the basis for a better management and follow-up of KS subjects.
PMID: 24001894 [PubMed - as supplied by publisher]

Source: European Journal of Endocrinology - September 3, 2013 Category: Endocrinology Authors: Selice R, Caretta N, Di Mambro A, Torino M, Palego P, Ferlin A, Foresta C Tags: Eur J Endocrinol Source Type: research